Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
•
Primary Care
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
Related Questions
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
How often do you monitor the eosinophil count after initiating anti-IL5 therapy for HAE?
What are the implications of checking post-vaccine titers after administration of Prevnar 20 compared to PPSV23?
How do you discuss the overlap of POTS, Ehlers-Danlos and MCAS with patients?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
Does food sensitivity testing for IgG subclasses help guide your management of food allergy?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
